Mr Jigar Shah
Founder and Managing Partner Ziva Intermediaries
Published by The Business Tycoons -
June 2026
Driving Innovation in Preventive Healthcare
- The pharmaceutical, biotechnology, medical devices, and nutraceutical sector is playing a transformative role in shaping the future of preventive and affordable healthcare worldwide. Driven by innovation, regulatory advancements, and growing global demand, the industry is rapidly evolving to deliver integrated healthcare solutions with a strong focus on quality, accessibility, and sustainability.
- Founded in 2020, Ziva Intermediaries LLP has emerged as an integrated pharmaceutical, biotechnology, medical devices, and nutraceutical startup committed to delivering end-to-end healthcare solutions. The company was established by Jigar Shah, who holds a Bachelor's degree in Pharmacy from Mumbai University and brings over 15 years of diversified industry experience spanning pharmaceuticals, medical devices, preventive medicine, and nutraceutical therapeutic supplements.
- “With a vision to bridge the critical gap between scientific innovation, affordable healthcare access, and scalable commercialization, Ziva Intermediaries LLP has positioned itself within the rapidly growing preventive healthcare ecosystem,” shares Mr. Shah.
- The company's strong foundation in science, quality, and global compliance has enabled it to collaborate successfully with pharmaceutical companies, biotech firms, research institutions, and healthcare organizations across multiple international markets.
Standing Apart
- What sets Ziva apart is its ability to seamlessly integrate scientific expertise with strategic execution. The company has built a distinctive reputation through its deep regulatory intelligence, leveraging global regulatory pathway expertise to accelerate approvals and facilitate smooth international expansion for its partners and proprietary brands.
- Operational excellence remains central to Ziva's business philosophy. By embedding rigorous operational processes directly into its strategic framework, the company has created a sustainable competitive advantage that enhances efficiency, scalability, and reliability.
- Innovation-driven research and development is another cornerstone of Ziva's success. The company has developed proprietary assets such as:
- ZIVROSE – an advanced hormonal balance solution
- ALCAPRO – an eco-sustainable vegan calcium formulation designed for systemic support
- Through its integrated value-chain model, Ziva manages the entire execution process — from earlystage innovation to full-scale commercialization — significantly reducing fragmentation and execution risks for clients and partners.
- Its rare combination of technical expertise and strategic advisory capabilities allows the company to deliver not only successful products but also longterm market leadership for its stakeholders.
Going Global
- Ziva Intermediaries LLP has already established a strong international footprint and continues to expand aggressively in global markets. The company currently supplies products and solutions to countries including Sri Lanka, Iraq, Iran, Algeria, France, Belgium, Greece, Germany and Dominican Republic.
